Cost benefit analysis of screening spina bifida
- PMID: 6166913
Item in Clipboard
Cost benefit analysis of screening spina bifida
N Z Med J.
.
Abstract
Cost benefit analysis of establishing and running a mass serum alpha-fetoprotein (AFP) screening service for neural tube defects (NTDS) in the Auckland Hospital Board area has been undertaken and a cost benefit index derived. From a population of 14 066 pregnant women per year, assuming present booking patterns continue, 8017 women could be screened for NTDS. Such screening could reduce severe spina bifida in liveborn babies by 38.8 percent.
Similar articles
-
When does mass screening for open neural tube defects in low-risk pregnancies result in cost savings?CMAJ. 1987 Feb 1;136(3):255-65. CMAJ. 1987. PMID: 2433011 Free PMC article.
-
[Alpha-fetoproteins in obstetrics].Gynakologe. 1983 Sep;16(3):148-54. Gynakologe. 1983. PMID: 6196260 Review. German. No abstract available.
-
The mortality and birth rates of spina bifida during a period of treatment, selection and antenatal screening in Sheffield, 1963-1978.Z Kinderchir Grenzgeb. 1979 Dec;28(4):294-301. Z Kinderchir Grenzgeb. 1979. PMID: 95238
-
Estimation of the levels of amniotic fluid alpha fetoprotein (AFP) for the prenatal diagnosis of spina bifida and anencephaly.Methods Find Exp Clin Pharmacol. 1981 Nov-Dec;3(6):391-5. Methods Find Exp Clin Pharmacol. 1981. PMID: 6173555
-
[Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against].Lakartidningen. 1995 Mar 22;92(12):1205-6, 1211-2. Lakartidningen. 1995. PMID: 7535873 Review. Swedish. No abstract available.
Cited by
-
When does mass screening for open neural tube defects in low-risk pregnancies result in cost savings?CMAJ. 1987 Feb 1;136(3):255-65. CMAJ. 1987. PMID: 2433011 Free PMC article.